China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.
Also called NCT01763320
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 380 participants
- Sponsor
- Registry
-
NCT01763320
-
- Other papers using this trial's data
- Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial
- Stenting Versus Medical Therapy for Symptomatic Intracranial Artery Stenosis: Long-Term Follow-Up of a Randomized Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01763320. Randomized; single masking; primary purpose treatment. Start 2014-03-05 (actual); primary completion 2016-11-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis
- Acronym
- CASSISS
- Condition
- Ischemic Stroke
- Intervention (Procedure)
- Intracranial stenting group
- Intervention (Drug)
- medical group
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct01763320- Content hash
b9c37a77c26fcf270cd3ff43dbda9656ca9a88028a80ed141638ace417a1eaf3